Human Papillomavirus High Carcinogenic Risk (Types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68), DNA, without genotyping [Real-time PCR]
Description
The test allows qualitative determination of the presence of genetic material of the causative agent of papillomavirus infection in the tested sample. It is used for screening for the most relevant carcinogenic types of the virus.
Period of execution
Within 2 days. The specified time does not include the day of biomaterial collection
Biomaterial type
- Urogenital scraping (PCR)